| Phase 2 Clinical Study in Psoriasis With Oral Investigational Drug VX-765 (NCT00205465) | Vertex Pharmaceuticals Incorporated | 2004-12-01 |
| Randomized Placebo-controlled Study of ISA247 in Plaque Psoriasis (NCT00244842) | Aurinia Pharmaceuticals Inc. | 2004-12-01 |
| A Multicentre, Open Label Phase IIIb/IV Study of Subcutaneously Administered Raptiva in the Treatment of Adult Subjects With Moderate to Severe Plaque Psoriasis (NCT00287118) | Merck KGaA, Darmstadt, Germany | 2004-10-27 |
| Study to Help Understand the Action of the Drug Etanercept for the Adult Patient With Psoriasis (NCT00116181) | Rockefeller University | 2004-10-01 |
| Study of Etanercept in the Treatment of Psoriasis in Adult Subjects (NCT00121615) | Amgen | 2004-10-01 |
| Etanercept (Enbrel®) in Psoriasis - Pediatrics (NCT00078819) | Amgen | 2004-09-08 |
| Safety and Efficacy Study of Two Dose Regimens of Becocalcidiol in the Treatment of Plaque-Type Psoriasis (NCT00373516) | QuatRx Pharmaceuticals Company | 2004-09-01 |
| Genetic Analysis of Psoriasis and Psoriatic Arthritis (NCT00341809) | National Cancer Institute (NCI) | 2004-07-30 |
| Follow-Up Study of Patients Previously Treated With Pimecrolimus Tablets for Chronic Plaque-Type Psoriasis (NCT00098189) | Novartis | 2004-07-01 |
| Study to Evaluate Effect of Pandel Cream 0.1% on HPA Axis in Pediatric and Adult Population (NCT01137032) | Fougera Pharmaceuticals Inc. | 2004-06-01 |
| A Study of Tetrathiomolybdate in the Treatment of Psoriasis Vulgaris (NCT00113542) | University of Michigan | 2004-06-01 |
| Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis (NCT00195676) | Abbott | 2004-05-01 |
| An Open-Label, Multi-Center Trial in the Treatment of Subjects With Moderate to Severe Plaque Type Psoriasis (NCT00725348) | Stiefel, a GSK Company | 2004-04-01 |
| The RATIO: Registry of Infections and Lymphoma in Patients Treated With TNF-a Antagonists (NCT00224562) | Assistance Publique - Hôpitaux de Paris | 2004-02-01 |
| Alefacept (Amevive) With or Without Narrowband UVB Treatment in Patients With Psoriasis. (NCT00407342) | Medical University of Graz | 2004-02-01 |
| Study of Therapeutic Options for Subjects Discontinuing Efalizumab and Experiencing Disease Recurrence (NCT01079988) | Merck KGaA, Darmstadt, Germany | 2004-02-01 |
| Role of CD7 in Skin Inflammation and Psoriasis (NCT00162825) | National Taiwan University Hospital | 2004-01-01 |
| Study of MEDI-522 Administered by Subcutaneous Injection to Adults With Plaque Psoriasis (NCT00192517) | MedImmune LLC | 2003-12-01 |
| Bexarotene With Narrow-Band UVB for Psoriasis (NCT00151008) | University of Medicine and Dentistry of New Jersey | 2003-11-01 |
| Extension Study of Two Dosing Schedules of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis (NCT00645892) | Abbott | 2003-11-01 |
| A Safety and Effectiveness Study of CNTO 1275 in Patients With Moderate to Severe Plaque-type Psoriasis (NCT00320216) | Centocor, Inc. | 2003-11-01 |
| Transitioning From Cyclosporine to Alefacept in Psoriasis (NCT00143806) | University of Medicine and Dentistry of New Jersey | 2003-10-01 |
| A Study to Evaluate Efalizumab in Adults With Plaque Psoriasis, Including Those Who Are Receiving Concomitant Antipsoriatic Therapies (NCT00338143) | Genentech, Inc. | 2003-10-01 |
| Study of the Drug Efalizumab (Raptiva), for Adult Patients With Moderate to Severe Plaque Psoriasis (NCT00115076) | Rockefeller University | 2003-08-04 |
| Evaluating the Safety of Etanercept 50 mg Twice Weekly in Subjects With Psoriasis (NCT00111449) | Amgen | 2003-06-01 |
| Assessment and Tracking of Long-term Alefacept Safety (NCT00454701) | Astellas Pharma Inc | 2003-06-01 |
| Study of Two Dosing Schedules of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis (NCT00645905) | Abbott | 2003-06-01 |
| Evaluating the Safety of Etanercept in the Treatment of Psoriasis in Adult Subjects (NCT00111436) | Amgen | 2003-04-01 |
| Multicenter Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis (NCT00645814) | Abbott | 2003-03-01 |
| Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis (NCT00646191) | Abbott | 2003-03-01 |
| A Study of the Safety and Effectiveness of Infliximab in Patients With Plaque-type Psoriasis (NCT00106847) | Centocor, Inc. | 2003-01-01 |
| Narrow-Band UVB-Therapy in Psoriasis (NCT00748020) | Radboud University Medical Center | 2003-01-01 |
| Elocon vs Fluticasone in Localized Psoriasis (P03197) (NCT00763529) | Organon and Co | 2003-01-01 |
| Psychiatric Problems in Chronic Skin Diseases (NCT00167752) | University of Wisconsin, Madison | 2002-12-01 |
| Multiple Dose Escalation Study In Medically Stable Subjects With Psoriasis (NCT01736696) | Pfizer | 2002-11-01 |
| Home UVB Phototherapy for Psoriasis: Effectiveness, Quality of Life and Cost-Effectiveness (NCT00150930) | UMC Utrecht | 2002-10-01 |
| A Study to Evaluate the Safety of Raptiva in Adults With Plaque Psoriasis Previously Enrolled in Study ACD2600g (NCT00096603) | Genentech, Inc. | 2002-10-01 |
| A Study to Evaluate Raptiva in Adults With Moderate to Severe Plaque Psoriasis Who Are Candidates for Systemic Therapy (NCT00109317) | Genentech, Inc. | 2002-09-01 |
| Long-Term Follow-Up Study of Psoriasis Patients (NCT00131066) | MedImmune LLC | 2002-08-01 |
| A Long-term Safety Study of Infliximab (Remicade) (NCT00261976) | Centocor, Inc. | 2002-02-01 |
| How Does Patients' Overall Assessment of Their Health Vary Across and Within Different Disease Groups? (NCT04359628) | Vastra Gotaland Region | 2002-01-01 |
| A Study to Evaluate Raptiva in Adults With Plaque Psoriasis Previously Enrolled in Study ACD2390g (NCT00109252) | Genentech, Inc. | 2002-01-01 |
| Open-label Study to Evaluate Safety of Multiple Courses of IM Alefacept During Treatment of Chronic Plaque Psoriasis (NCT00692172) | Astellas Pharma Inc | 2001-12-01 |
| BIRB 796 BS Versus Placebo in Patients With Moderate to Severs Plaque-type Psoriasis (NCT02209753) | Boehringer Ingelheim | 2001-06-01 |
| Research in Skin Inflammation (NCT00026741) | National Cancer Institute (NCI) | 2001-03-01 |
| Study of MEDI-507 Administered by Intravenous Infusion to Adults With Plaque Psoriasis (NCT00192452) | MedImmune LLC | 2001-03-01 |
| Micellar Paclitaxel to Treat Severe Psoriasis (NCT00006276) | National Cancer Institute (NCI) | 2000-09-01 |
| Conditioning, the Placebo Effect, and Psoriasis (NCT00005922) | University of Rochester | 2000-08-01 |
| Scalp Psoriasis Treatment With a Fiber Optic Comb (NCT00007293) | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 2000-08-01 |
| Ultraviolet (UVA and UVB) Light Therapy in the Treatment of Inflammatory Skin Conditions (NCT00129415) | University of Michigan | 2000-08-01 |
| Study of Topical Calcitriol in Children With Psoriasis (NCT00006275) | National Center for Research Resources (NCRR) | 2000-07-01 |
| Assessment of Digital Imaging as a Tool for Diagnosing Psoriasis, Hand Rashes and Unusual Moles (NCT00005781) | National Cancer Institute (NCI) | 2000-05-01 |
| CYA Versus MMF for Treatment of Moderate-Severe Psoriasis. (NCT00295425) | University Hospital Muenster | 2000-05-01 |
| Double-blind, Randomized, Placebo-controlled Phase 3 Study of Etanercept in the Treatment of Psoriatic Arthritis and Psoriasis (NCT00317499) | Amgen | 2000-04-01 |
| Randomized Double-Blind Placebo-Controlled Trial Using Recombinant Human Interleukin-10 for Moderate-to-Severe Psoriasis (NCT00001797) | National Cancer Institute (NCI) | 1999-01-01 |
| Study of Topical Calcitriol or Oral Calcitriol in Patients With Psoriasis (NCT00004468) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1998-10-01 |
| To Study the Use of Humanized CD25 in Preventing the Relapse of Psoriasis Vulgaris (NCT00050661) | Rockefeller University | 1997-10-01 |
| To Study the Effects of CD25 and Low Dose Cyclosporin in the Treatment of Active Psoriasis Vulgaris (NCT00050648) | Rockefeller University | 1997-10-01 |
| A Controlled Trial of Intermittent Fludarabine for Psoriatic Arthritis (NCT00001422) | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 1995-06-01 |
| Study of Psoriatic Arthritis (NCT00001420) | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 1995-03-01 |
| Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity (NCT03941184) | Mayo Clinic | 1995-01-01 |
| A Pilot Study of Topical Antiflammin-2 for Psoriasis (NCT00001371) | National Cancer Institute (NCI) | 1993-12-01 |
| The Evaluation of Oral Acitretin in the Treatment of Psoriasis, Cutaneous Disorders of Keratinization, Multiple Basal Cell Carcinomas and Other Retinoid Responsive Diseases (NCT00005660) | National Cancer Institute (NCI) | 1977-10-01 |
| Chondroitin Sulphate Efficay/Safety in Patients With Knee Osteoarthritis and Psoriasis (NCT00669123) | Bioiberica | |
| A Study to Assess the Safety and Effectiveness of Tacrolimus Cream in the Treatment of Psoriasis (NCT00293891) | Astellas Pharma Inc | |
| A Study to Assess the Safety and Effectiveness of Tacrolimus Cream in the Treatment of Psoriasis (NCT00293930) | Astellas Pharma Inc | |
| A Study of Retrovir in the Treatment of Psoriasis in HIV-Positive Patients (NCT00002286) | Glaxo Wellcome | |
| Safety and Efficacy Study of Bimosiamose Cream to Treat Psoriasis (NCT00823693) | Revotar Biopharmaceuticals AG | |
| Enbrel® in Psoriatic Arthritis (NCT00111124) | Amgen | |
| Treatment of Psoriasis Using Acitretin in HIV-Positive Patients (NCT00002143) | Hoffmann-La Roche | |
| An Evaluation of Etanercept in the Treatment of Subjects With Psoriasis (NCT00111111) | Amgen | |
| A Study of the Safety and Efficacy of Infliximab in Patients With Psoriasis (NCT00106834) | Centocor, Inc. | |
| A Safety and Efficacy Study of Infliximab (Remicade) in Patients With Plaque Type Psoriasis (NCT00230529) | Centocor, Inc. | |